This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Icagen, Inc.. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: The Innovations of Ping Hu
Introduction
Ping Hu is an accomplished inventor based in Bethesda, MD (US). He has made significant contributions to the field of biotechnology, particularly in the study of human potassium channels. His work has implications for both therapeutic and prophylactic applications.
Latest Patents
Ping Hu holds a patent for a nucleic acid encoding the human potassium channel K⁺ nov1 protein. This patent outlines methods for isolating K⁺Hnov genes. The K⁺Hnov nucleic acid compositions are useful in identifying homologous or related proteins and the DNA sequences encoding such proteins. Additionally, they can be used to produce compositions that modulate the expression or function of the protein. His research also explores the modulation of gene activity in vivo for various applications, including the identification of cell types based on expression.
Career Highlights
Ping Hu is currently associated with Icagen, Inc., where he continues to advance his research in the field. His work has garnered attention for its potential to impact medical science and therapeutic strategies.
Collaborations
He has collaborated with notable colleagues, including Mark Edward Curran and Andrew Miller, contributing to a dynamic research environment.
Conclusion
Ping Hu's innovative work in biotechnology exemplifies the intersection of research and practical application. His contributions to the understanding of potassium channels are paving the way for future advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile